FIELD: chemistry.
SUBSTANCE: invention refers to a peritoneal therapeutic fluid containing one or more biocompatible agents (BCA) and one or more ingredients selected from alkali metal ions, alkaline-earth metal ions, osmotic agent and/or pH buffer substance. Biocompatibility enhancing agent is selected from a group comprising stilbenoids, phenolic acids, flavones, anthocyanidins, a salt thereof and a glycoside. Peritoneal therapeutic fluid is used as a peritoneal fluid for dialysis or peritoneal therapeutic fluid with reduced cytotoxicity with respect to human peritoneal mesothelial cells. Also described is a container or kit for peritoneal therapeutic fluid.
EFFECT: technical result is reduced cytotoxic side effects.
27 cl, 13 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOHYDRATE COMPOSITIONS FOR DIALYSIS | 2018 |
|
RU2749443C2 |
| PERITONEAL DIALYSATE | 2007 |
|
RU2429822C1 |
| BIOCOMPATIBLE AQUEOUS SOLUTION FOR PERFORMING CONTINUOUS PERITONEAL AMBULATORY DIALYSIS | 1996 |
|
RU2158593C2 |
| TUMOUR TREATMENT AGENT AND KIT CONTAINING LIPOSOMAL GEMCITABINE COMPOSITION | 2016 |
|
RU2761620C2 |
| SOLUTION FOR PERITONEAL DIALYSIS | 2014 |
|
RU2567043C1 |
| AGENT FOR TREATING A TUMOR AND A KIT CONTAINING A LIPOSOMAL COMPOSITION OF GEMCITABINE | 2016 |
|
RU2738365C2 |
| AGENT FOR TREATING TUMOUR AND KIT CONTAINING LIPOSOMAL COMPOSITION OF GEMCITABINE | 2016 |
|
RU2768178C2 |
| PLATINUM NANOCOMPOUNDS AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2538199C2 |
| ALDEHYDE DERIVATIVES OF SIALIC ACID, METHODS OF THEIR OBTAINMENT, CONJUGATES OF ALDEHYDE DERIVATIVES OF SIALIC ACID, AND PHARMACEUTICAL COMPOSITION BASED ON THEM | 2004 |
|
RU2333223C2 |
| PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS | 1992 |
|
RU2118531C1 |
